Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥234.19 Million ≈ $34.27 Million USD) by net assets (CN¥6.97 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guizhou Xinbang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Guizhou Xinbang Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PC Jeweller Limited
NSE:PCJEWELLER
|
0.005x |
|
Zhejiang Yasha Decoration Co Ltd
SHE:002375
|
-0.009x |
|
Shenzhen Urovo Technology Co Ltd
SHE:300531
|
0.058x |
|
China CYTS Tours Holding Co Ltd
SHG:600138
|
0.044x |
|
Suning Universal Co Ltd
SHE:000718
|
0.008x |
|
Foshan Saturday Shoes Co Ltd
SHE:002291
|
-0.028x |
|
MA Financial Group Ltd
AU:MAF
|
0.847x |
|
Wuhan Xingtu Xinke Electronics Co Ltd
SHG:688081
|
-0.047x |
Annual Cash Flow Conversion Efficiency for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 002390 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
CN¥634.97 Million ≈ $92.92 Million |
0.090x | -18.29% |
| 2023-12-31 | CN¥7.14 Billion ≈ $1.05 Billion |
CN¥790.62 Million ≈ $115.69 Million |
0.111x | +32.38% |
| 2022-12-31 | CN¥7.07 Billion ≈ $1.03 Billion |
CN¥590.80 Million ≈ $86.45 Million |
0.084x | +24.68% |
| 2021-12-31 | CN¥6.83 Billion ≈ $999.22 Million |
CN¥457.97 Million ≈ $67.02 Million |
0.067x | -53.29% |
| 2020-12-31 | CN¥5.17 Billion ≈ $756.31 Million |
CN¥742.11 Million ≈ $108.59 Million |
0.144x | -18.22% |
| 2019-12-31 | CN¥5.05 Billion ≈ $738.73 Million |
CN¥886.33 Million ≈ $129.70 Million |
0.176x | +515.18% |
| 2018-12-31 | CN¥5.17 Billion ≈ $756.32 Million |
CN¥-218.56 Million ≈ $-31.98 Million |
-0.042x | -241.67% |
| 2017-12-31 | CN¥6.76 Billion ≈ $989.00 Million |
CN¥201.74 Million ≈ $29.52 Million |
0.030x | +197.48% |
| 2016-12-31 | CN¥6.49 Billion ≈ $948.96 Million |
CN¥-198.59 Million ≈ $-29.06 Million |
-0.031x | -137.59% |
| 2015-12-31 | CN¥2.67 Billion ≈ $390.56 Million |
CN¥217.40 Million ≈ $31.81 Million |
0.081x | +200.81% |
| 2014-12-31 | CN¥2.46 Billion ≈ $359.67 Million |
CN¥-198.60 Million ≈ $-29.06 Million |
-0.081x | -292.27% |
| 2013-12-31 | CN¥1.04 Billion ≈ $151.59 Million |
CN¥-21.34 Million ≈ $-3.12 Million |
-0.021x | +42.23% |
| 2012-12-31 | CN¥1.02 Billion ≈ $149.64 Million |
CN¥-36.46 Million ≈ $-5.34 Million |
-0.036x | +12.39% |
| 2011-12-31 | CN¥979.53 Million ≈ $143.34 Million |
CN¥-39.87 Million ≈ $-5.83 Million |
-0.041x | -1661.76% |
| 2010-12-31 | CN¥959.70 Million ≈ $140.43 Million |
CN¥2.50 Million ≈ $365.97K |
0.003x | -98.42% |
| 2009-12-31 | CN¥252.83 Million ≈ $37.00 Million |
CN¥41.75 Million ≈ $6.11 Million |
0.165x | +37.96% |
| 2008-12-31 | CN¥207.69 Million ≈ $30.39 Million |
CN¥24.86 Million ≈ $3.64 Million |
0.120x | -35.86% |
| 2007-12-31 | CN¥174.08 Million ≈ $25.47 Million |
CN¥32.49 Million ≈ $4.75 Million |
0.187x | +266.24% |
| 2006-12-31 | CN¥144.17 Million ≈ $21.10 Million |
CN¥7.35 Million ≈ $1.07 Million |
0.051x | -- |
About Guizhou Xinbang Pharmaceutical Co Ltd
Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more